Advanced search
Publication Cover
Acta Oncologica Volume 31, 1992 - Issue 5
Journal homepage
90
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Carcinoma of Unknown Primary Site a Complete and Sustained Response with Interleukin-2, alpha Interferon and 5 Fluorouracil/Leucovorin

Harish P. G. Dave Mount Vernon Cancer Institute, Alexandria, VA; George Washington University Medical Center, Washington, DC, USA
,
Chiristine I. White Mount Vernon Cancer Institute, Alexandria, VA; George Washington University Medical Center, Washington, DC, USA
,
Richard Schulof Mount Vernon Cancer Institute, Alexandria, VA; George Washington University Medical Center, Washington, DC, USA
&
Frederick P. Avis Mount Vernon Cancer Institute, Alexandria, VA
Pages 592-593 | Received 01 Feb 1992, Published online: 08 Jul 2009

References

  • Moertel C G, Reitmeier R J, Schutt A J, Hahn R G. Treatment of the patient with adenocarcinoma of unknown origin. Cancer 1972; 30: 1469–72
  • Sporn J R, Greenberg B R. Empiric chemotherapy in patients with carcinoma of unknown primary site. Am J Med 1990; 88: 49–55
  • Greenberg B R, Lawrence H J. Metastatic cancer with unknown primary. Med Clin North Am 1988; 72: 1055–65
  • Altmain E, Cadman E. An analysis of 1–539 patients with cancer of unknown primary site. Cancer 1986; 57: 120–4
  • Goldberg R M, Smith F P, Ueno W, Ahlgren J D, Schein P S. S-fluorouracil, Adriamycin, and mitomycins in the treatment of adenocarcinoma of unknown primary. J Clin Oncol 1986; 4: 395–9
  • Woods R L, Fox R M, Tattersall M HN, Levi J A, Brodic G N. Metastatic carcinoma of unknown primary site: A randomized study of two combination chemotherapy regimens. N Engl J Med 1980; 303: 87–9
  • Papa M Z, Yang J C, Vetto J T, Shiloni E, Eisenthal A, Rosenberg S A. Combined erects of chemotherapy and interleukin-2 in the therapy of mice with advanced pulmonary turmors. Cancer Res 1988; 48: 122–9
  • Wadler S, Schwartz E L, Goldman M, et al. Fluorouracil and recombinant alpha-2a-interferon: An active regimen against advanced colorectal carcinoma. J Clin Oncol 1989; 7: 1769–7
  • Rosenberg S A, Lotze M T, Yang J C, et al. Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients. Ann Surg 1989; 210: 474–85
  • Schulof R, Goldberg S, Holmlund J, Mehlman T, White C, Avis F. Outpatient recombinant interleukin-2 + alpha-interferon alternating with 5-Ruorouracil/leukovorin for metastatic colorectal and breast cancer. Society for Biotherapy 1990

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.